Treatment options currently available to diabetics are limited to imperfect solutions, as both patients and caretakers will attest. Painful, bulky, time-consuming insulin delivery methods abound, and the industry knows it. Therefore, the company that finds an all-in-one solution that makes life easier for patients with diabetes also knows there’s a payday in store.

Cue the artificial pancreas. The drug delivery device–combining an insulin pump with a glucose monitor for complete, automated control over insulin dosage–has occupied the sights of several big names in the diabetes arena, giving rise to several iterations currently moving forward in clinical trials.

Click here to see the advancements being made in the development of an artificial pancreas.